Many neurological diseases are poorly understood with limited treatment options. Traditional NGS approaches miss important details like structural variants and RNA isoforms, leading to misinterpretations, undiagnosed and untreated neurological conditions. Unravel the complexity of neuroscience by accessing more comprehensive and accurate data with PacBio Revio at the Duke University Sequencing and Genomic Technologies Core Facility.
Featured Topics
- Global challenges in translational neuroscience research & local solutions
- HiFi WGS for ALS drug discovery and development
- Transcriptome level discovery and isoform characterization in Parkinson's Disease
Monday, October 28, 2024
Lunch & Learn: 12:00 – 1:15 PM
Networking Session/Q&A: 1:15 – 2:00 PM
Duke South Clinic Davison – Markee Lecture Hall Room 224
Join online via Zoom (passcode: 476996)
Lunch & Learn + Networking Session
Speakers
Masha Strømme, PhD | Board of Directors Chair, GenieUs
Richard Bedlack, MD PhD | Stewart, Hughes, and Wendt Distinguished Professor of ALS; Director of Duke ALS Program & Scientific Advisory Board Member, GenieUs
Nadia Sellami, PhD | PacBio Segment Lead, Neuroscience & Biopharma
Webb Pierson, MS | Ornit Chiba-Falek Lab, Duke University